Evidence for sequence selection within the non-structural 5A gene of hepatitis C virus type 1b during unsuccessful treatment with interferon-α

Journal of Viral Hepatitis

Volumn 6, Issue 5, 1999, Pages 367-372

  Gerotto, M ^a   Dal Pero, F ^a   Sullivan, D G ^b   Chemello, L ^a   Cavalletto, L ^a   Polyak, S J ^b   Pontisso, P ^a   Gretch, D R ^b   Alberti, A ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Clonal frequency analysis; HCV infection; IFN resistance; NS5A ISDR

Indexed keywords

ALPHA INTERFERON;

ADULT; ARTICLE; CLINICAL ARTICLE; FEMALE; GENE SEQUENCE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; VIRUS GENE; VIRUS STRAIN;

ADULT; AMINO ACID SEQUENCE; ANTIVIRAL AGENTS; DRUG RESISTANCE, MICROBIAL; FEMALE; HEPACIVIRUS; HEPATITIS C; HUMANS; INTERFERON-ALPHA; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; SEQUENCE ANALYSIS, DNA; VIRAL NONSTRUCTURAL PROTEINS;

EID: 0032886421     PISSN: 13520504     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2893.1999.00166.x     Document Type: Article

References (19)

1. Hepatitis Branch Centers for Disease Control and Prevention. 1997 Hepatitis C Fact Sheet. Atlanta, GA: Centers for Disease Control and Prevention, 1997.
2. Alter MJ, Margolis HS, Krawczynski K et al. The natural history of community-acquired hepatitis C in the United States. N Engl J Med 1992; 327: 1899-1905.
3. McHutchison JG, Gordon SC, Shiff ER et al. Interferon alpha-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. N Engl J Med 1998; 339: 1485-1492.
4. Davis GL, Esteban-Mur RM, Rustgi V et al. Interferon alpha-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C. N Engl J Med 1998; 339: 1493-1499.
5. Hoofnagle JH, Di Bisceglie AM. The treatment of chronic viral hepatitis. N Engl J Med 1997; 336: 347-356.
6. Enamoto N, Sakuma I, Asahina Y et al. Comparison of full-length sequences of interferon-sensitive and resistant hepatitis C virus 1b. J Clin Invest 1995; 96: 224-230.
7. Enamoto N, Sakuma I, Asahina Y et al. Mutation in the nonstructural protein 5A gene and response to interferon in patients with chronic hepatitis C virus 1b infection. N Engl J Med 1996; 334: 77-81.
8. Gale MJ, Korth MJ, Tang NM et al. Evidence that the hepatitis C virus resistance to interferon is mediated through repression of PKR protein kinase by the nonstructural 5A protein. Virology 1997; 230: 217-227.
9. Korsi H, Castelain S, Wyseur A et al. Mutations of hepatitis C virus 1b NS5A 2209-2248 amino acid sequence do not predict the response to recombinant interferon alpha therapy in French patients. J Hepatol 1997; 27: 72-77.
10. Zeuzem S, Lee JH, Roth WK. Mutations in the nonstructural 5A gene of European hepatitis C virus isolates and response to interferon alpha. Hepatology 1997; 25: 740-744.
11. Martell M, Esteban JI, Quer J et al. Hepatitis C virus (HCV) circulates as a population of different but closely related genomes: quasispecies nature of HCV genome distribution. J Virol 1992; 66: 3225-3229.
12. Polyak SJ, McArdle S, Liu SL et al. Evolution of hepatitis C virus quasispecies in the hypervariable region 1 and the interferon sensitivity determining region during interferon therapy and natural infection. J Virol 1998; 72: 4288-4296.
13. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium-thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162: 156-159.
14. Wilson JJ, Polyak SJ, Day TD, Gretch DR. Characterization of simple and complex hepatitis C virus quasispecies by heteroduplex gel shift analysis: correlation with nucleotide sequencing. J Gen Virol 1995; 76: 1763-1771.
15. Gretch DR, Bacchi CE, Corey L et al. Persistent hepatitis C virus infection following liver transplantation: clinical and virologic features. Hepatology 1995; 22: 1-9.
16. Polyak SJ, Faulkner G, Carithers RL Jr, Corey L, Gretch D. Assessment of hepatitis C virus quasispecies heterogeneity by gel shift analysis: correlation with response to interferon therapy. J Infect Dis 1997; 175: 1101-1107.
17. Squadrito G, Leone F, Sartori M et al. Mutations in the nonstructural 5A region of hepatitis C virus and response of chronic hepatitis C to interferon alpha. Gastroenterology 1997; 113: 567-572.
18. Sàiz J-C, Lòpez-Labrador F-X, Ampurdnés S et al. The prognostic relevance of the nonstructural 5A gene interferon sensitivity determining region is different in infections with genotype 1b and 3a isolates of hepatitis C virus. Infect Dis 1998; 177: 839-847.
19. Chayama K, Tsubota A, Kabayashi M et al. Pretreatment virus load and multiple amino acid substitutions in the interferon sensitivity determining region predict the outcome of interferon treatment in patients with chronic genotype 1b hepatitis C virus infection. Hepatology 1997; 25: 745-749.